Diseases causing end-stage renal failure in New South Wales.
The nature of the original renal disease was determined in 403 consecutive cases of end-stage renal failure, in 317 of which the clinical diagnosis was corroborated by histological examination of the kidney. Five diseases accounted for 20 or more cases--glomerulonephritis (31% of the total), analgesic nephropathy (29%), primary vesicoureteral reflux (8%), essential hypertension (6%), and polycystic kidneys (5%). In only four cases did renal failure result from chronic pyelonephritis without a demonstrable primary cause. Greater use of micturating cystography and cystoscopy and routine urine testing for salicylate are advocated for earlier diagnosis of the major causes of "pyelonephritis". The incidence of end-stage renal failure in people aged 15-55 in New South Wales was estimated to be at least 34 new cases per million of total population each year.
D000082:Acetaminophen / Q000009:adverse effects; D000328:Adult; D000700:Analgesics / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D001315:Australia; D002110:Caffeine / Q000009:adverse effects; D003061:Codeine / Q000009:adverse effects; D003558:Cystoscopy; D005260:Female; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006977:Hypertension, Renal / Q000150:complications; D007674:Kidney Diseases / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000209:etiology*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010615:Phenacetin / Q000009:adverse effects; D007690:Polycystic Kidney Diseases / Q000150:complications; D011704:Pyelonephritis / Q000453:epidemiology; D006435:Renal Dialysis; D012457:Salicylamides / Q000009:adverse effects; D012459:Salicylates / Q000652:urine; D014184:Transplantation, Homologous; D014567:Urography; D014718:Vesico-Ureteral Reflux / Q000150:complications
D000700:Analgesics; D012457:Salicylamides; D012459:Salicylates; D000082:Acetaminophen; D002110:Caffeine; D010615:Phenacetin; D001241:Aspirin; D003061:Codeine